Losartan Dosing to Complement Amlodipine 2.5 mg for Hypertension
Start losartan at 50 mg once daily and titrate to 100 mg once daily after 2–4 weeks if blood pressure remains ≥140/90 mmHg. 1, 2
Initial Dosing Strategy
- Begin with losartan 50 mg once daily as the standard starting dose for hypertension when adding to amlodipine 2.5 mg. 1, 2
- The 50 mg starting dose is appropriate regardless of the concurrent low-dose amlodipine, as this represents the FDA-approved initial dose for essential hypertension. 2
- Administer losartan at any convenient time of day to promote adherence; it can be taken with or without food. 1, 3
Titration to Target Dose
- Increase to losartan 100 mg once daily after 2–4 weeks if office blood pressure remains ≥140/90 mmHg or home readings stay ≥135/85 mmHg. 1, 2
- The maximum FDA-approved dose for hypertension is 100 mg daily, which can be given as a single dose or split into 50 mg twice daily for more consistent 24-hour coverage. 1, 2, 3
- Reassess blood pressure every 2–4 weeks during titration, aiming for a target of <130/80 mmHg within 3 months of therapy initiation. 1
Monitoring Requirements
- Check serum creatinine/eGFR and potassium within 1–2 weeks after starting losartan or increasing the dose, especially if the patient has diabetes, chronic kidney disease, or is taking potassium-sparing agents. 1
- Monitor blood pressure in both sitting and standing positions in elderly patients (≥65 years) to detect orthostatic hypotension. 1
- Continue monitoring at least annually during maintenance therapy once blood pressure is controlled. 1
If Blood Pressure Remains Uncontrolled
After 4–8 Weeks on Losartan 100 mg + Amlodipine 2.5 mg:
- First, increase amlodipine from 2.5 mg to 5 mg daily before adding a third agent, as 2.5 mg is a subtherapeutic dose and the standard starting dose is 5 mg. 1
- If blood pressure remains ≥140/90 mmHg on losartan 100 mg + amlodipine 5–10 mg, add hydrochlorothiazide 12.5–25 mg once daily to create triple therapy (ARB + CCB + thiazide diuretic). 1
- Prefer single-pill fixed-dose combinations when available (e.g., losartan/hydrochlorothiazide) to markedly improve adherence. 1
For Resistant Hypertension (Uncontrolled on Triple Therapy):
- Add spironolactone 25 mg daily as the fourth agent; it is the most effective add-on in resistant hypertension. 1
Critical Safety Considerations
- Never combine losartan with an ACE inhibitor or direct renin inhibitor (aliskiren); dual RAAS blockade increases the risk of hyperkalemia, syncope, and acute kidney injury by 2–3-fold without cardiovascular benefit. 1, 2
- Losartan is absolutely contraindicated in pregnancy due to serious fetal toxicity (renal dysfunction, oligohydramnios, skull hypoplasia, fetal death); discontinue immediately if pregnancy is detected. 1, 2
- Monitor for hyperkalemia, especially when combined with potassium supplements, potassium-sparing diuretics, or NSAIDs. 1
Special Population Adjustments
- Hepatic impairment (mild-to-moderate): Start at 25 mg once daily due to 5-fold higher plasma concentrations. 1, 2
- Elderly or frail patients (≥75 years): Initiate at the standard 50 mg dose but titrate more gradually (every 2–4 weeks rather than weekly) and monitor closely for dizziness, falls, and symptomatic hypotension. 1
- Volume depletion (e.g., on diuretics): Consider starting at 25 mg once daily to reduce hypotension risk. 2
Common Pitfalls to Avoid
- Do not leave amlodipine at 2.5 mg indefinitely; this is a subtherapeutic dose and should be increased to at least 5 mg (the standard starting dose) before adding multiple additional agents. 1
- Do not add a beta-blocker as second- or third-line therapy unless there is a compelling indication (heart failure, post-MI, angina, atrial fibrillation), as beta-blockers are less effective than CCBs or diuretics for stroke prevention. 1
- Confirm medication adherence through direct questioning before escalating therapy, as non-adherence is the most common cause of apparent treatment failure. 1
- Do not stop losartan prematurely for mild creatinine elevations (0.1–0.3 mg/dL increase); this reflects expected hemodynamic changes rather than tubular injury unless urinalysis shows acute tubular necrosis. 1